Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2007;38:1799-1804
Published online before print April 26, 2007, doi: 10.1161/STROKEAHA.106.472282
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/6/1799    most recent
STROKEAHA.106.472282v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christoforidis, G. A.
Right arrow Articles by Yang, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christoforidis, G. A.
Right arrow Articles by Yang, M.
Related Collections
Right arrow Thrombolysis
Right arrow Acute Cerebral Infarction
Right arrow Emergency treatment of Stroke
Right arrow Intracerebral Hemorrhage

(Stroke. 2007;38:1799.)
© 2007 American Heart Association, Inc.


Original Contributions

Size Matters

Hemorrhage Volume as an Objective Measure to Define Significant Intracranial Hemorrhage Associated With Thrombolysis

Gregory A. Christoforidis, MD; Andrew Slivka, MD; Yousef Mohammad, MD; Christopher Karakasis, BS; Bindu Avutu, MPH Ming Yang, MD

From the Departments of Radiology and Neurology, The Ohio State University College of Medicine, Columbus, Ohio.

Correspondence to Gregory A. Christoforidis, MD, 627 Means Hall, 1654 Upham Dr, The Ohio State University Medical Center, Columbus, OH 43210. E-mail greg.christoforidis{at}osumc.edu

Background and Purpose— This study defines significant thrombolysis associated intracranial hemorrhage (ICH) by identifying an objective threshold volume that predicts clinical deterioration attributable to ICH.

Methods— Prospectively collected clinical and radiographic information, from 103 consecutive patients who underwent intraarterial thrombolysis for acute ischemic stroke, was reviewed. Multiple paired comparisons between stratified hematoma volume and change in National Institutes of Health Stroke Scale (NIHSS) score by 24 to 36 hours and by time of hospital discharge was used to identify significant differences. Associations between hemorrhage volume and infarct volume in relation to clinical outcomes were examined. Rates of hemorrhagic transformation (HT), symptomatic hemorrhage, and parenchymal hematoma involving over 30% of the infarct were compared with hemorrhage volume. Multivariate regression analysis was used to determine the relationship between change in discharge NIHSS score and hemorrhage volume adjusting for known predictors of clinical outcomes.

Results— Multiple paired comparisons indicate that hemorrhage greater than 25 mL (HV25) had a more distinct impact on NIHSS score by time of hospital discharge than at 24 to 36 hours. Twenty-seven (26.2%) patients had HT and 12 (11.7%) had HV25. Among symptomatic hemorrhage, parenchymal hematoma involving over 30% of the infarct, and HV25, HV25 appeared more reflective of clinical deterioration from ICH. Hemorrhage volume increased with infarct volume but they were independently associated with change in NIHSS score on regression analysis.

Conclusion— Clinical deterioration from ICH and ischemic injury are more effectively distinguished at time of hospital discharge. The authors propose to define significant hemorrhage associated with thrombolysis as hemorrhage volume greater than 25 mL.


Key Words: acute stroke • interventional neuroradiology • intracerebral hemorrhage • thrombolysis • thrombolytic RX